A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures.

• To assess the efficacy, safety, and tolerability of adjunctive carisbamate treatment at 800 mg/day and 1,200 mg/day in patients with partial-onset seizures (POS).

Keyword

Adult

Anticonvulsants

administration & dosage

adverse effects

Carbamates

administration & dosage

adverse effects

Double-Blind Method

Drug Administration Schedule

Drug Therapy

Combination

methods

Epilepsies

Partial

diagnosis

drug therapy

Female

Humans

Male

Middle Aged

Outcome Assessment (Health Care)

methods

Publication and Content Type

ref (subject category)

art (subject category)